Today's Research Reports on Trending Tickers: GlaxoSmithKline and Eli Lilly and Company
NEW YORK, NY / ACCESSWIRE / November 6, 2018 / U.S. equities closed mostly higher on Monday as investors awaited details from the Fed's two-day policy meeting and midterm congressional elections. The Dow Jones Industrial Average gained 0.76 percent to close at 25,461.70, while the S&P 500 Index increased 0.56 percent to close at 2,738.31. The Nasdaq Composite Index dropped 0.38 percent to close at 7,328.85, pressured by losses from major tech players Apple and Amazon.
According to Ryan Nauman, market strategist at Informa Financial Intelligence, "There's a lot of headlines that investors are going to have to sift through this week." "With everything going on, I expect more volatility" as election approaches, Nauman added.
RDIInitiates Coverage on:
GlaxoSmithKlineplc
https://rdinvesting.com/news/?ticker=GSK
Eli Lillyand Company
https://rdinvesting.com/news/?ticker=LLY
GlaxoSmithKline’s stock jumped 3.12% Monday, to close the day at $40.05. The stock recorded a trading volume of 2,860,893 shares, which was above its three months average volume of 2,439,731 shares. In the last year, GlaxoSmithKline's shares have traded in a range of 34.52 - 42.36. The share price has gained 16.02% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $39.73 is below its 200-day moving average of $40.34. Shares of the company are trading at a Price to Earnings ratio of 45.31. Shares of GlaxoSmithKline have gained roughly 0.6 percent in the past month and are up 12.91 percent year-to-date.
AccessRDI's GlaxoSmithKline plc Research Report at:
https://rdinvesting.com/news/?ticker=GSK
On Monday, shares of Eli Lilly and Company recorded a trading volume of 7,367,694 shares, which was above the three months average volume of 3,950,139 shares. The stock ended the day 3.18% higher at $110.14. The share price has fallen 5.55% from its 52 week high with a 52 week trading range of 73.69 - 116.61. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $109.13 is above its 200-day moving average of $95.62. Shares of Eli Lilly and Company have fallen roughly 4.24 percent in the past month and are up 30.4 percent year-to-date.
AccessRDI's Eli Lilly and Company Research Report at:
https://rdinvesting.com/news/?ticker=LLY
Our Actionable Research on GlaxoSmithKline plc (NYSE:GSK) and Eli Lilly and Company (NYSE:LLY) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
